LIRAGLUTIDE SUN 6 mg/ml, solution for injection in a pre-filled pen 2 pens of 3 ml
Active ingredients: Liraglutide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 pens of 3 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LIRAGLUTIDE SUN 6 mg/mL, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 2 cartouches en verre dans stylo pré-rempli de 3 mL
- Marketing authorisation holder
- SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64959498CIP73031118CIP133400930311189Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIRAGLUTIDEsolution | 6 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.